TRIGEMINAL PALSY

This adverse event was reported 46 times

TRIGEMINAL PALSY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRACAINE HYDROCHLORIDE 1 0.0075
1 LIDOCAINE HCL 3% 2 0.0044
2 SODIUM THIOSULFATE 2 0.0036
3 CILTACABTAGENE AUTOLEUCEL 7 0.0011
4 ELRANATAMAB-BCMM 1 0.0009
5 IDECABTAGENE VICLEUCEL 1 0.0008
6 NELFINAVIR MESYLATE 1 0.0005
7 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 3 0.0004
8 BUPIVACAINE 3 0.0003
9 GADODIAMIDE 1 0.0003
See all drugs enriched for association with TRIGEMINAL PALSY

TRIGEMINAL PALSY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 3 0.0016
1 Cytolytic Agent [EPC] 1 0.0004
2 Paramagnetic Contrast Agent [EPC] 1 0.0002
3 Ester Local Anesthetic [EPC] 7 0.0001
4 Amide Local Anesthetic [EPC] 9 0.0001
5 Quinolone Antimicrobial [EPC] 1 0.0001
6 Non-Standardized Chemical Allergen [EPC] 7 0.0001
7 Antiarrhythmic [EPC] 9 0.0001
8 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
9 Catecholamine [EPC] 4 0.0000
See all drug classes enriched for association with TRIGEMINAL PALSY